Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features
about
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinomaMultifaceted Roles of ALG-2 in Ca(2+)-Regulated Membrane TraffickingThe TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studiesMolecular basis for defect in Alix-binding by alternatively spliced isoform of ALG-2 (ALG-2DeltaGF122) and structural roles of F122 in target recognitionInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaGenetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility.TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53.Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGEPrognostic factors in resected lung carcinomas.Alternative splicing of TAF6: downstream transcriptome impacts and upstream RNA splice control elements.Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosisPDCD6 is an independent predictor of progression free survival in epithelial ovarian cancerIdentification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing.CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activationVariations in the PDCD6 gene are associated with increased uterine leiomyoma risk in the Chinese.Expression of Transforming Growth Factor β1 and E-Cadherin Proteins in Pulmonary Adenocarcinoma: Its Significance in Tumor ProgressionStructure and function of ALG-2, a penta-EF-hand calcium-dependent adaptor protein.T-cadherin modulates tumor-associated molecules in gallbladder cancer cells.Nuclear ALG-2 protein interacts with Ca2+ homeostasis endoplasmic reticulum protein (CHERP) Ca2+-dependently and participates in regulation of alternative splicing of inositol trisphosphate receptor type 1 (IP3R1) pre-mRNA.Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma.MiR-124 inhibits invasion and induces apoptosis of ovarian cancer cells by targeting programmed cell death 6.What are the radiologic findings predictive of indolent lung adenocarcinoma?Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancersALG-2 participates in recovery of cells after plasma membrane damage by electroporation and digitonin treatment
P2860
Q24657797-F6705EA4-821E-4C3F-AFF4-AAAC1DC9B8E0Q26738429-3367F837-13C6-4B2C-8075-45CC553A8E3EQ26830803-0CCD64ED-466B-46BE-8FAB-CD5FD2004411Q27663895-C773E30B-A0A7-43FF-9ED0-012B96EC6CCBQ28303718-1341E025-08CB-4B9D-8823-F5DBD187271DQ33418117-9426C493-5941-49E3-9CAF-B4FFB05F69FAQ33526062-1B700DD2-2D12-40ED-9508-ACB2B816FB00Q33531797-405E4FA1-22A0-4EA2-8E2B-1741C69F1026Q33697964-23ADB1AE-5EE5-470C-B9AC-1EA9D7CC1EE8Q33905777-E104003B-79AD-4016-93C2-48D9E1F4330BQ34612346-2BEB740C-3DBD-493C-A6F0-24B3FBB7ACF9Q35834117-4F3F2774-50E9-4A5A-8CBC-3084B12710D8Q36545951-7ADBDE0E-DDFE-439A-A852-75E822EF1F01Q36562284-1BF285D8-5F51-4503-ADE0-3201511444DBQ36979515-B197BCA7-52AC-403C-B200-CF21CDF11436Q37011129-140ED141-B5F8-412E-B943-95DD4A80451FQ37904897-7DE08D34-432E-4B34-B39A-94BDDC0A00B6Q39745464-227E4BFE-4F68-4FDA-AF1F-5A3DAB61EE6FQ42135943-0CA63677-76C1-4B66-B47D-49FEF20F8680Q42265507-D32DD2F9-713F-4B93-89EB-6152D796C98BQ45774420-9555F477-5262-4B8F-8E8F-54C081E407B2Q46833966-CEA755CE-CA10-4A3D-9353-3DC489BB8C6EQ47552047-C7917F1F-42EF-4E0D-BF5E-DB308CD1911DQ53633599-1ABE80C9-BE89-41E0-87D4-21C5A3211758Q54210512-F1B81A30-A527-496E-ACB1-2C4710717B76Q54980290-45F8E226-43AA-4DE6-8274-F896E96277CBQ57462591-860B697E-4628-4B50-880B-0D693B5EAFDDQ58707221-374097A6-EA48-4E94-97BE-C08AB9BC689E
P2860
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Genomic markers for malignant ...... th bronchioloalveolar features
@ast
Genomic markers for malignant ...... th bronchioloalveolar features
@en
type
label
Genomic markers for malignant ...... th bronchioloalveolar features
@ast
Genomic markers for malignant ...... th bronchioloalveolar features
@en
prefLabel
Genomic markers for malignant ...... th bronchioloalveolar features
@ast
Genomic markers for malignant ...... th bronchioloalveolar features
@en
P2093
P2860
P356
P1476
Genomic markers for malignant ...... th bronchioloalveolar features
@en
P2093
Bradley P Coe
Chang-Qi Zhu
Dan Strumpf
Igor Jurisica
Sarit Aviel-Ronen
Suzanne K Lau
P2860
P304
10155-10160
P356
10.1073/PNAS.0709618105
P407
P577
2008-07-15T00:00:00Z